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ABSTRACT: The genetic missense A30P mutation of the wild-type α-synuclein
protein results in the replacement of the 30th amino acid residue from alanine (Ala)
to proline (Pro) and was initially found in the members of a German family who
developed Parkinson’s disease. Even though the structures of these proteins have
been measured before, detailed understanding about the structures and their
relationships with free energy landscapes is lacking, which is of interest to provide
insights into the pathogenic mechanism of Parkinson’s disease. We report the
secondary and tertiary structures and conformational free energy landscapes of the
wild-type and A30P mutant-type α-synuclein proteins in an aqueous solution
environment via extensive parallel tempering molecular dynamics simulations along
with thermodynamic calculations. In addition, we present the residual secondary
structure component transition stabilities at the atomic level with dynamics in terms
of free energy change calculations using a new strategy that we reported most
recently. Our studies yield new interesting results; for instance, we find that the A30P mutation has local as well as long-range
effects on the structural properties of the wild-type α-synuclein protein. The helical content at Ala18-Gly31 is less prominent in
comparison to the wild-type α-synuclein protein. The β-sheet structure abundance decreases in the N-terminal region upon
A30P mutation of the wild-type α-synuclein, whereas the NAC and C-terminal regions possess larger tendencies for β-sheet
structure formation. Long-range intramolecular protein interactions are less abundant upon A30P mutation, especially between
the NAC and C-terminal regions, which is linked to the less compact and less stable structures of the A30P mutant-type rather
than the wild-type α-synuclein protein. Results including the usage of our new strategy for secondary structure transition
stabilities show that the A30P mutant-type α-synuclein tendency toward aggregation is higher than the wild-type α-synuclein but
we also find that the C-terminal and NAC regions of the A30P mutant-type α-synuclein are reactive toward fibrillzation and
aggregation based on atomic level studies with dynamics in an aqueous solution environment. Therefore, we propose that small
molecules or drugs blocking the specific residues, which we report herein, located in the NAC- and C-terminal regions of the
A30P mutant-type α-synuclein protein might help to reduce the toxicity of the A30P mutant-type α-synuclein protein.
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The α-synuclein (αS) protein is a 140 amino acid residueintrinsically disordered fibrillogenic protein that is the
main component of the large aggregates, termed Lewy bodies,
which are a pathological hallmark of Parkinson’s disease as well
as other neurodegenerative disorders.1−6 Genetic variants
involving either a missense mutation or triplication of the
gene for the αS protein have been isolated in familial forms of
Parkinson’s disease.7−10 For example, a genetic missense
mutation that results in the mutation of the Ala30 residue to
a Pro residue, or the A30P mutation, was initially found in the
members of a German family who developed Parkinson’s
disease.8 The exact role of αS in the disease mechanism remains
poorly understood, partially due to the difficulties associated
with measuring the structures of intrinsically disordered
fibrillogenic proteins at the monomeric and oligomeric levels.
Monomeric and oligomeric forms of intrinsically disordered
fibrillogenic proteins determine the aggregation mecha-
nism.11,12 Furthermore, the monomeric and oligomeric forms
of αS are proposed to be the neurotoxic species in the
pathogenic mechanism of Parkinson’s disease due to the crucial
role of their structural properties in the aggregation
process.13,14 However, studies performed with conventional
tools face challenges in the measurements of monomeric αS
protein structures due to fast aggregation, rapid conformational
changes, and solvent effects. Besides these difficulties, detailed
understanding of the structures and conformational free energy
landscapes of the wild-type and A30P mutant-type αS proteins
in solution can provide the currently missing detailed
knowledge about the effect of the A30P genetic missense
mutation on the αS protein, which in turn furnishes the
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required information for gaining more insights into the disease
mechanism and designing more efficient treatments.
Interestingly, the current literature involves a debate about
the structural properties of the A30P mutant-type αS protein. It
was reported that the fibril structure of the A30P mutant-type
αS is similar to that of the wild-type αS protein.14−19 Despite
this, the aggregation kinetics, neurotoxicity, and oligomeric
structural properties of the wild-type αS were shown to be
affected by the A30P mutation. Specifically, various exper-
imental studies have reported that the A30P mutation results in
an increase in the rate of oligomerization and aggregation of αS
while the rate of fibril formation is decreased in comparison to
the wild-type αS.11,12,14,15,20−23 However, Ono et al. reported
that the A30P mutation decelerates the rate of oligomeriza-
tion.24 The A30P mutant-type αS is also reported to be more
neurotoxic than the wild-type αS, which has been linked to the
reported increased oligomerization rate upon A30P muta-
tion.23,25−27 Even though far-ultraviolet-circular dichroism (far-
UV-CD) measurements do not reveal secondary structural
differences between the wild- and mutant-type αS proteins,12,15
various other measurements have presented that the conforma-
tional behavior of A30P mutant-type αS differs from that of the
wild-type αS protein. Bertoncini et al. reported via nuclear
magnetic resonance (NMR) measurements that the long-range
interactions of the A30P mutant-type αS are reduced in
comparison to the wild-type αS protein.28 Furthermore, it was
shown that the A30P mutation affects the formation of helical
structure around the location of the mutation.28,29 An increase
in β-sheet conformation was observed for αS upon A30P
mutation by single molecule force (SMF) and Fourier
transform infrared (FTIR) spectroscopies.11,12,30 Utilizing far-
UV-CD and Förster resonance energy transfer (FRET)
measurements, Deniz and co-workers demonstrated that the
folding landscape of the αS protein in the presence of sodium
dodoceyl sulfate (SDS) is shifted from a three-state to a two-
state transition upon A30P mutation.31 In addition, the
interaction of αS with lipid vesicles and membranes was
shown to be less abundant in the A30P mutant-type αS
monomer in comparison to its oligomeric state.13,32
Theoretical studies can complement experiments and
provide structural and thermodynamic information at the
atomic level with dynamics. For example, recent successful
studies by Carloni and co-workers reported various structural
properties; average distance between residues, radius of
gyration and structural flexibility of the wild-type and A53T
mutant-type human αS and wild-type mouse αS obtained from
molecular dynamics (MD) simulations using an explicit model
for water.33 Yet, the secondary structural properties per residue
of these three αS proteins were not reported in this study.
Furthermore, the impacts of the confined aqueous volume
effect on the reported results are unknown. Moreover,
Chatterjee et al. reported transient decreases to the helical
structure around the mutation site in the A30P mutant-type αS
via classical MD simulations.34 However, MD simulations
without the usage of special sampling techniques face
limitations in configurational sampling of the full-length
intrinsically disordered fibrillogenic proteins that lack a stable
structure and suffer from the multiple minima problem.
Furthermore, the variations in the secondary and tertiary
structures as well as free energy landscapes were not presented
in these earlier studies. Annealing molecular dynamics
simulations by Balesh et al. presented a decrease in α-helix
structure in the A30P mutant-type αS protein structures but an
increase in the 310-helix abundance and no change in the β-
sheet structure formation upon A30P mutation of the wild-type
αS.35 Detailed information about the tertiary structure and
conformational free energy landscape differences was not
reported. Furthermore, Perlmutter et al. demonstrated
successfully that the destabilization of the secondary structure
around the mutation site in the A30P mutant-type αS
decreased interactions with a micelle via MD simulations
without the usage of special sampling techniques.36 In addition,
Kumar et al.60 performed classical MD simulations on the
structures of the wild-type and A30P mutant-type αS proteins.
Even though interesting information was presented, the
secondary and tertiary structures of the A30P mutant-type
protein were not discussed in their study.
Figure 1. Wild-type and A30P mutant-type αS secondary structure components. Secondary structure component abundances per residue for the
wild-type (black) and A30P mutant-type (red) αS structures obtained after convergence. The abundances for the π-helix and coil structures are not
displayed.
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To the best of our knowledge, an in depth, atomic-level
comparison of the impact of the A30P mutation on the
structural and thermodynamic properties of the wild-type αS
protein in aqueous solution that includes secondary and tertiary
structures as well as the dependence of these properties on the
free energy landscapes has not yet been presented in the
literature. In this study, we compare the secondary and tertiary
structural properties as well as the free energy landscapes of the
wild-type and A30P mutant-type αS proteins in an aqueous
solution environment at the atomic level with dynamics. We
also studied the secondary structure transition stabilities at the
atomic level with dynamics using our in-house developed
method that we presented most recently. To achieve these
results, we have performed extensive all-atom parallel temper-
ing MD simulations, which is one type of special sampling
technique that enhances conformational sampling of protein
structures, on the full-length wild-type and A30P mutant-type
αS proteins. From these simulations, we have obtained
interesting trends in the secondary and tertiary structural
properties and thermodynamic preferences of the wild-type and
A30P mutant-type αS that provide insight into the proposed
differences in aggregation kinetics of these two proteins. We
also investigated the potential of mean force (PMF) surfaces of
these two proteins, which we previous applied successfully on
the wild-type and mutant-type amyloid-β proteins in the
vicinity and absence of cofactors.37−39 Additionally, the
application of our newly in house developed theoretical
strategy and software package (ProtMet), which we presented
most recently, has enabled insights into the dynamic stabilities
between secondary structure component conversions per
residue in an aqueous solution medium.39,40
■ RESULTS AND DISCUSSION
Figure 1 presents the calculated residual secondary structure
components with dynamics of the wild-type and A30P mutant-
type αS proteins in an aqueous solution medium. The helical
and β-sheet structure formations have been proposed to play
crucial roles in the aggregation process of intrinsically
disordered fibrillogenic proteins at the center of neuro-
degenerative diseases.12,14,24,41 Within the N-terminal region
(Met1-Lys60) of the wild-type and A30P mutant-type αS, we
detect abundant α-helix formation at Ala19-Lys23 and 310-helix
formation at Val15-Ala18, Glu20-Thr22, Gly41-Thr44, and
Thr54-Lys60 varying between 20% and 35% (Figure 1).
Interestingly, Gly7-Glu13, Val15-Ala17, Lys32-Val40, and
Lys43-Gly47 adopt more prominent helical structure (α-helix
or 310-helix; up to 30%) in the structures of the A30P mutant-
type than in those of the wild-type αS protein. In contrast, the
α-helix and 310-helix contents at Gly25-Lys32 in the wild-type
αS protein structures decrease or disappear upon A30P
mutation. This finding is in agreement with the NMR
measurements that reported reduced helical propensity for
Ala18-Gly31 upon A30P mutation.28,29 Moreover, our results
are in partial agreement with those of Chatterjee and Sengupta,
who presented a decrease in helix abundance around the
mutation site of the A30P mutant-type αS in comparison to the
wild-type αS, by MD simulations.34 Bussell and Eliezer
proposed that destabilization of helix formation in this region
may be associated with the increased rate of oligomerization of
the A30P mutant-type rather than wild-type αS.29 Con-
sequently, our results suggest an increase in oligomerization
rate of the A30P mutant-type αS in comparison to the wild-
type. We detect abundant helical structure formation (>20%) in
the nonamyloid β component region (NAC; Glu61-Val95) at
Glu61-Val63, Thr75-Gln79, and Ser87-Ala89 in the conforma-
tions of the wild-type and the A30P mutant-type αS proteins.
Furthermore, the α-helical content at Thr75-Gln79 is up to 9%
larger in the structures of A30P mutant-type rather than wild-
type αS. However, the 310-helix abundance at Glu61-Gln62
decreases (up to 30%) upon A30P mutation of the wild-type αS
protein. The α-helix abundance in the C-terminal region is
similar for both wild-type and A30P mutant-type αS, with the
highest abundance observed at Lys96-Gly101. Nevertheless, we
do observe more abundant α-helix formation at Pro108-Ile112
in the A30P mutant-type structures in comparison to the wild-
type αS structures in an aqueous solution environment. In
addition, Gly111-Glu114 and Gly132 located in the C-terminal
region present abundant 310-helix formation (up to 28%) for
both the wild-type and A30 mutant-type αS proteins. We also
note a larger decrease in 310-helix abundance (≥5%) at Phe94-
Leu100 in the A30P mutant-type structures rather than those of
the wild-type αS protein.
Abundant β-sheet structures (5% to 20%) are formed in parts
of the NAC and C-terminal regions (Val70, Val71, Val82,
Glu83, Ala89-Ala91, Lys102, Asn103, Pro108, and Gln109) in
the structures of the wild-type αS protein. A similar trend is
observed for the A30P mutant-type αS structures with a
significant increase in β-sheet formation at Val66, Gly67, Ile88,
Ala89, Val95-Gln99, Gly101, Lys102, and Pro108-Glu114.
These findings support previous NMR measurements that
reported β-sheet structure in the C-terminal region of both the
wild- and A30P mutant-type αS proteins.29 Furthermore, SMF
and FTIR spectroscopic measurements reported increased β-
sheet conformation for the A30P mutant-type αS structures in
comparison to those of the wild-type αS protein struc-
tures.11,12,30 In contrast to our findings, previous annealing
MD simulations performed by Balesh et al. did not show an
increase in β-sheet formation in the A30P mutant-type αS
structures in comparison to those of the wild-type αS protein.35
Additionally, we find that the N-terminal region possesses
abundant β-sheet structure (≥5% probability) at Phe4, Glu13,
Val16, Gln24, Val26, Ala27, Thr33-Glu35, and Val37 in the
wild-type αS conformations that disappears in the structures of
the A30P mutant-type αS protein. This result supports the
NMR measurements performed by Bussell and Eliezer, who
suggested a possible decrease in β-sheet formation upon A30P
mutation in the N-terminal region of the wild-type αS
protein.29 We also note that β-sheet abundance decreases at
Val82, Glu83, Ala90 and Ala91 upon A30P mutation of the
wild-type αS protein. As mentioned above, β-sheet structure
formation has been linked to the aggregation process.11,12,14
Therefore, and based on our findings, the N-terminal region of
A30P mutant-type αS is less likely to participate in the
aggregation process than the same region in the wild-type αS
protein. Furthermore, our results predict that the C-terminal
region and part of the NAC region of A30P mutant-type αS are
more reactive toward aggregation than the same regions in the
wild-type αS protein. These findings support the experimental
findings that report a faster rate of oligomer formation for the
A30P mutant-type αS in comparison to the wild-
type.11,12,14,15,20−23 We should mention here again that β-
sheet formation is associated with the self-association and
aggregation of αS, including the formation of dimeric,
oligomeric, and fibril structures.11,12,14 Furthermore, β-sheet
formation in the NAC region was proposed to play an
important role in the intermolecular interactions between the
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monomeric species.29 Therefore, the increased β-sheet
structure formation in the NAC and C-terminal regions that
we find upon A30P mutation may be associated with the
reported larger oligomerization rate that was detected for the
A30P mutant-type oligomers. The N-terminal region and β-
sheet formation in this region was also proposed to be crucial in
fibril formation, yet we detect a decrease in β-sheet formation
in the N-terminal region, which indicates rather an inhibition of
fibril formation via the N-terminal region.17,29,42,43 Abundant
(up to 55%) turn structure formation occurs in the C-terminal
region of the wild- and A30P mutant-type αS proteins. Large
decreases in the tendencies toward turn structure formation
occur in the N-terminal region at Glu28-Pro30 and in the C-
terminal region (Gln109-Asp115) with a difference up to 30%.
However, turn structure abundance is increased at Thr33,
Val40, Thr44-Gly47, Glu57-Glu61, Val63, Thr64, Glu130, and
Glu131 (≥5%) upon A30P mutation of the wild-type αS
protein.
In addition to determining the abundance of the formation of
specific secondary structure components, we also calculated the
free energy change values for the transitions between two
different secondary structure components for each residue of
the wild-type and A30P mutant-type αS proteins (Figure 2)
using our recently developed theoretical strategy.39,40 The free
energy values identify which secondary structure transitions are
most preferred and thus can be used to identify which
structures are most likely to precede the formation of secondary
structure components of interest. These calculations show turn
or helix to coil transitions as well as helix to turn or turn to helix
transitions are overall the most preferred secondary structure
transitions for both the wild-type and A30P mutant-type αS
proteins in an aqueous solution environment. Due to the
proposed importance of helical and β-sheet structures in the
aggregation mechanism of αS proteins, the transitions to and
from these structures are of particular interest. In the N-
terminal region, transitions from turn to helix structures are the
most preferred at Val3-Lys60 in the wild-type αS protein
(Figure 2, top). Even though transitions to a β-sheet structure
are generally less preferred than transitions to helical structure
in the N-terminal region of the wild-type αS, we do note that
coil to β-sheet transitions present the same thermodynamic
preference as turn to helix and coil to helix transitions for
residues Phe4 and Glu13. Upon A30P mutation of the wild-
type αS, the thermodynamic stability of transitions to a helix
structure from any other secondary structure (turn, coil or β-
sheet) at Gln24-Gly31 decreases (Figure 2, bottom). Instead,
we observe an increase in preference for turn to coil transitions
for these residues. Furthermore, Pro30 shows an increase in
preference for transitions to a β-sheet structure in comparison
to the Ala30 residue of the wild-type αS. In contrast, the
remaining residues of the N-terminal region present a
decreased thermodynamic preference for all transitions to a
β-sheet structure. Turn to helix transition is also most preferred
in the NAC region of both the wild-type and A30P mutant-type
αS proteins. Additionally, coil to β-sheet transitions present a
similar thermodynamic preference as the turn to helix
transitions for residues Ala90 and Ala91 in the wild-type αS
and residues Val66, Gly67, and Ala89 in the A30P mutant-type
αS. In the C-terminal region, turn to coil transition is the most
stable overall. However, specific residues in the C-terminal
region display different preferred secondary structure compo-
nent transitions. For example, turn to helix transition is the
most stable conversion at Lys96-Lys102 for both the wild- and
mutant-type proteins. Turn or coil to helix as well as helix to
turn secondary structure transitions are not preferred at
Met116-Asp199 in the wild-type αS protein. Yet, the
thermodynamic stability of these transitions increases upon
A30P mutation of αS for the same residues. We also note that
coil to β-sheet transition is preferred at Lys102, Asn103,
Pro108, and Gln109 in the C-terminal region of the wild-type
αS. In the A30P mutant-type αS, coil to β-sheet transitions are
preferred at Gln99, Gly101, Lys102, and Pro108-Glu110. In
addition, stable helix to β-sheet transition is detected at Lys97-
Gln99, Gly111, and Ile112; stable β-sheet to helix transition
occurs at Lys97 and Asp98. We also note an overall increase in
the preference of bisecondary structure component transitions
resulting in the formation of a β-sheet structure as well as β-
sheet to helix transition at Lys96-Glu114 upon A30P mutation
of the wild-type αS protein. In contrast, a vice versa trend
occurs for residues located at Asp115-Ala140 in the C-terminal
region. Overall, these findings are in agreement with NMR
measurements that are described above but provide in-depth
insights into the residual bisecondary structure transition
stabilities that are currently not assessable experimentally
using conventional tools.
Figure 2. Wild-type and A30P mutant-type αS secondary structure
transition stabilities. The stability of secondary structure transitions
between two specific secondary structure components per residue for
the wild-type (WT) and A30P mutant-type (A30P) αS proteins based
on extensive Gibbs free energy calculations performed using our
recently developed theoretical strategy. The color scale corresponds to
the free energy value associated with the specific secondary structure
transition between two secondary structure components for a specific
residue.
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The calculated intramolecular protein interactions in the
structures of the wild-type and A30P mutant-type αS proteins
are presented in Figure 3. We detect strong intramolecular
interactions between Gly86-Asn103 in the NAC region and
Glu104-Asn122 in the C-terminal region with an abundance
larger than 50% in the structures of the wild-type αS protein
(Figure 3, top). Furthermore, Val70-Gly84 and Ala85-Leu100
in the NAC region of the wild-type αS protein present strong
intramolecular interactions (up to 90%). We also note
prominent interactions between Ala56-Gly106 and Gly84-
Gln134 (up to 40%). Thus, we find moderate interactions
between the N-terminal, NAC and C-terminal regions with the
NAC and C-terminal regions. Overall, these tertiary structure
findings agree with the previous theoretical studies performed
by Carloni and co-workers.33 Interestingly, the intramolecular
interactions in the structures of the wild-type αS are
significantly influenced by the A30P mutation (Figure 3,
bottom). Even though some intramolecular interactions
between a part of the NAC region (Ile88-Asn103) and the
C-terminal region (Glu104-Pro120) occur, the abundances of
these interactions are decreased in the A30P mutant-type αS in
comparison to the wild-type αS structures. Moreover, abundant
(up to 40%) intramolecular interactions occur between Lys58-
Val95 and the C-terminal region (Lys96-Pro128). Intra-
molecular interactions between the N-terminal region (Val26-
Lys58) and the NAC and C-terminal regions (Gln62-Leu100)
are also detected. However, intramolecular interactions
between the N-terminal region (Met1-Lys60) and Val118-
Val140 of the C-terminal region disappear upon A30P mutation
of the wild-type αS monomer in an aqueous solution medium.
Similar trends are also detected for the intramolecular
interactions between residues Met1-Val16 of the N-terminal
region and the NAC region. This finding along with the
decreased intramolecular interactions between the NAC and C-
terminal regions of the A30P mutant-type αS presents that the
NAC region is more solvent exposed in the A30P mutant-type
rather than in the structures of the wild-type αS protein. The
reduced long-range intramolecular interactions as well as the
increased exposure of the NAC region upon A30P mutation of
the wild-type αS protein agree with some previous NMR
measurements of the wild-type and A30P mutant-type αS.28
Furthermore, the less abundant long-range interactions and
increased exposure of the NAC region have been proposed to
potentiate the aggregation of the wild-type αS protein by
allowing the NAC region, which is proposed to be a key in the
fibrillogenesis process, to be more available for intermolecular
interactions with surrounding monomers rather than intra-
molecular interactions.28,44,45 Therefore, our tertiary structure
findings along with our secondary structure property
investigations present that the A30P mutant-type αS protein
tends to be more reactive toward aggregation than the wild-
type αS, which is in agreement with some experimental
measurements.11,12,14,20−22 Time-resolved fluorescence energy-
transfer measurements reported an increased donor to acceptor
distance upon A30P mutation of αS, which agrees with our less
compact structure of A30P mutant-type αS in comparison to
the wild-type αS.46 The same trend is also obtained in the
probability distribution of the radius of gyration (Rg) for both
proteins (Figure 4). Specifically, the probability of the
structures with an Rg value between 22.3 Å and 31.8 Å is
larger for the wild-type than the A30P mutant-type αS
structures, whereas, the vice versa trend is obtained for Rg
values varying between 31.0 and 38.3 Å. Although the wild-type
structures present a slightly higher probability for structures
with Rg values varying between 38.8 and 43.8 Å and between
47.4 and 48.9 Å than the A30P mutant-type αS, the opposite
trend is detected for Rg values larger than 44.0 Å. NMR
Figure 3. Wild-type and A30P mutant-type αS tertiary structures.
Calculated intramolecular interactions of the wild-type (WT) and the
A30P mutant-type (A30P) αS. The color scale corresponds to the
probability (P) of the distance between the heavy atoms (C, N, O, S)
of a residue being ≤20 Å from each other.
Figure 4. Wild-type and A30P mutant-type αS radius of gyration
values. The probability distribution of the radius of gyration (Rg)
values of the wild-type (black) and A30P mutant-type (red) αS for the
structures obtained after convergence.
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measurements also predicted a decrease in long-range
interactions in the structures of the A30P mutant-type αS
rather than the wild-type αS protein, which agrees overall with
our observed decreased compactness of the wild-type αS
protein upon A30P mutation.28 We also note that the
probability distribution of Rg values of the wild-type αS agrees
with the range of Rg values reported by previous theoretical
studies by Losasso et al.33
The thermodynamic values, specifically the conformational
Gibbs free energy values (G) including conformational
enthalpic (H) and entropic (TS) contributions, for the
structures of the wild-type and A30P mutant-type αS proteins
are presented in Table 1. The conformational Gibbs free energy
provides a quantitative estimate of the relative stability of the
wild-type and A30P mutant-type αS structures in aqueous
solution. Based on the difference in conformational Gibbs free
energy values, the structures of the wild-type αS protein are
more stable by 79.4 kJ mol−1 than those of the A30P mutant-
type αS in an aqueous medium. The less stable A30P mutant-
type αS structures might be more reactive toward aggregation
than the structures of the wild-type αS protein based on these
Gibbs free energy calculations. Our thermodynamic results
support our structural property findings that we describe above
as well as some experiments, which predicted the oligomeriza-
tion and aggregation rate of the A30P mutant-type αS protein
to be increased in comparison to the wild-type αS
protein.11,12,14,20−22 Comparing the enthalpic and entropic
contributions to the conformational Gibbs free energies reveals
that the wild-type αS is enthalpically more preferred than the
A30P mutant type by 96 kJ mol−1, whereas a vice versa trend is
observed for the entropic contribution (13.5 kJ mol−1).
Following our previous studies with intrinsically disordered
fibrillogenic proteins at the center of neurodegenerative
disease,37−40 we assessed the structural preferences of the
wild-type and A30P mutant-type αS using PMF surfaces along
the coordination of Rg and end-to-end distance (RE‑E) as
presented in Figure 5. The PMF surfaces assess the favorability
of protein conformations including solvent effects on these
structures based on specific structural parameters, in this case
the Rg and RE‑E values. Due to their intrinsically disordered
nature, different conformations of the αS protein may have
similar thermodynamic stability, resulting in the presence of
multiple basins of structures with similar thermodynamic
characteristics. Determining the different structural character-
istics (secondary and tertiary structures) of the conformations
located in these different basins provides insights into the
structural parameters that influence the stability of the wild-
type and A30P mutant-type αS structures in aqueous solution.
The free energy landscape of the wild-type αS shows two most
favorable PMF basins (Figure 5, top). Specifically, one of the
favorable PMF basins (basin IA) is located at Rg values varying
between 28.0 and 35.5 Å and RE‑E values varying between 51
Table 1. Calculated average enthalpy (H), solvation free energy (Gsol), H−Gsol, Entropy (TS), and Gibbs Free Energy (G)
Values for the Wild-Type (WT) and A30P Mutant-Type (A30P) α-Synuclein Proteins
peptide ⟨Etotal⟩ (kJ mol
‑1) ⟨Gsol⟩ (kJ mol
‑1) ⟨H⟩ (kJ mol‑1) T⟨S⟩ (kJ mol‑1) ⟨G⟩ (kJ mol‑1)
WT 7146.5 (±174.3) −16 704.1 (±169.7) −9557.4 (±18.4) 7043.8 (±8.4) −16 601.4 (±13.0)
A30P 7861.6 (±240.8) −17 323.0 (±200.0) −9461.4 (±50.8) 7057.3 (±18.8) −16 518.7 (±32.1)
Figure 5. Wild-type and A30P mutant-type αS PMF surfaces. Change in the potential of mean force (ΔPMF) of the wild-type (WT) and A30P
mutant-type (A30P) αS along the coordinates of radius of gyrations (Rg) and end-to-end distance (RE‑E) in units of kJ mol
−1. The reference value for
the PMF surfaces are 6.73 and 6.48 kJ mol−1 for the wild-type and A30P mutant-type αS, respectively.
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and 98 Å. The second most favorable PMF basin (basin IB) for
the wild-type αS structures is located at Rg values varying
between 37.4 and 42 Å and RE‑E values varying between 108
and 148 Å. The PMF surface of the wild-type αS structures
indicates that the transitions between the structures located in
basin IA to basin IB or vice versa may require the overriding of
large energy barriers (>1kT). The free energy landscape of the
A30P mutant-type αS structures also presents two most
favorable PMF basins (Figure 5, bottom). The first basin
(basin IA) is located at Rg values varying between 30.5 and 36.5
Å and RE‑E values varying between 86 and 136 Å while the
second favorable basin (basin IB) is located at Rg values
between 37.0 and 41.5 Å and RE‑E values between 122 and 144
Å. Unlike the wild-type αS protein structures, transitions
between the basin IA and basin IB structures of the A30P
mutant-type αS protein do not require the overriding of large
energy barriers.
In addition to identifying the location of the favorable basins
along the PMF surfaces, the secondary and tertiary structural
characteristics of the structures located in each of these basins
for the wild-type and A30P mutant-type αS were calculated.
The secondary structural components of each PMF basin for
the wild-type and A30P mutant-type αS are presented in Figure
6. Differences in the secondary structural components of the
structures in the two most favorable PMF basins (basin IA and
basin IB) exist for both the wild-type and A30P mutant-type αS
proteins. For the wild-type αS protein, the most abundant α-
helix structure in the conformations located in basin IA occurs
in the C-terminal region (Phe94-Gly101; up to 56%) but the α-
helix content decreases by 30% for these residues in the
structures located in basin IB. On the other side, the basin IB
structures of the wild-type αS present the most abundant α-
helix structure at Glu20-Val26, Lys32-Gly36, and Lys28-Thr64
in the N-terminal and NAC regions (up to 46%). The basin IA
Figure 6. Wild-type and A30P mutant-type αS secondary structure components of the PMF basin structures. Calculated secondary structure
abundances per residue for the structures of the wild-type (WT) and A30P mutant-type (A30P) αS located in basin IA (purple), basin IB(blue),
basin II (green) and basin III (red) along the PMF surface. The abundances for the π-helix and coil structures are not displayed.
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structures possess α-helix formation at these residues but with a
decreased abundance than the basin IB wild-type αS structures.
We also observe abundant α-helix at Met5, Lys6, Glu28, Ala29,
Leu38, Val40-Lys43, Glu61, Lys80-Glu83, and Ala89-Thr92 in
the N-terminal and NAC regions of the basin IA structures,
whereas the basin IB structures present additional abundant α-
helix formation at Leu8, Val55, Ala56, and Val77. For the A30P
mutant-type αS protein, a similar trend exists in the α-helix
content differences between the basin IA and basin IB
structures. The basin IA structures of the A30P mutant-type
αS present the most abundant α-helix formation at Phe94-
Leu100 in the C-terminal region that decreases in the basin IB
structures. However, the basin IB structures present the most
abundant α-helix formation (up to 42%) in the N-terminal
region at Val3-Glu13, whereas, the same residues in the basin
IA structures form an α-helical structure with smaller.
Abundant α-helical structure is also detected in the N-terminal
and NAC regions at Ala19-Lys23, Lys32-Glu46, Glu61, and
Thr75-Ala78 in the basin IA structures and at Val16-Gln24,
Lys32-Gly41, Lys43, Thr44, Val74, and Thr75 in the basin IB
structures of the A30P mutant-type αS protein.
The wild-type αS presents abundant 310-helix formation
throughout the N-terminal and NAC regions as well as at a few
residues in the C-terminal region for both the basin IA and
basin IB structures (≥20%). However, the 310-helix content is
significantly increased (up to 40%) in the basin IB structures in
comparison to the basin IA structures of the wild-type αS at
Val15-Ala17, Gly25-Gly31, Gly36-Leu38, Val40-Ser42, Gly86-
Ile88, Val95-Gln99, and Gly101. On the other hand, Lys43-
Lys45, Gln79-Ala85, and Asp121-Tyr125 present the vice versa
trend between the 310-helix content of the basin IA and basin IB
structures of the wild-type αS protein with a difference in
abundance up to 12%. The A30P mutant-type αS protein
presents abundant 310-helix formation throughout the N-
terminal and NAC regions as well as at residues located in
the C-terminal region. However, the differences in abundance
between the basin IA and basin IB structures are not as
prominent as in the wild-type αS protein. Furthermore, Gly36-
Leu38, Gly41-Thr44, and Val77-Glu83 present more abundant
310-helix structure in the basin IA structures in comparison to
the basin IB structures of the A30P mutant-type αS. The vice
versa trend is obtained for Thr54-Glu61 and Val71-Ala76 of the
A30P mutant-type αS protein. Notable variations in the β-sheet
formation of the wild-type and A30P mutant-type αS between
the most favorable PMF basins are also observed. Specifically,
the basin IA structures of the wild-type αS present abundant α-
helix formation (>10%) at residues Val16, Gln24, Glu35, Val70,
Val71, Lys102, and Pro108. However, the basin IB structures
present abundant β-sheet structure at residues Phe4, Glu13,
Val82, Glu83, Ala90, Ala91, and Gln109 with an abundance of
up to 60%. In comparison, the A30P mutant-type αS presents
abundant β-sheet formation at similar residues in the NAC and
Figure 7.Wild-type and A30P mutant-type αS tertiary structures of the favorable PMF basin structures. Calculated intramolecular interactions of the
wild-type αS structures located in basin IA (WT IA) and basin IB (WT IB) of the PMF surface and of the A30P mutant-type αS structures located in
basin IA (A30P IA) and basin IB (A30P IB) of the PMF surface. The color scale corresponds to the probability (P) of the distance between the
heavy atoms (C, N, O, S) of a residue being ≤20 Å from each other.
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C-terminal regions in both the basin IA and basin IB structures.
Nevertheless, a decrease in abundance is observed for residues
Gly101, Lys102, Gly111, and Ile112 in the basin IA structures
in comparison to the basin IB structures.
The intramolecular interactions of the structures located in
the most favorable PMF basins (basin IA and IB) of the wild-
type present notable differences between the two PMF basins
(Figure 6 top and bottom, respectively). Specifically, the
structures of the wild-type αS located in basin IA present
abundant intramolecular interactions between Gly86-Glu104
with Glu105-Ala124 and Val70-Glu83 (between 50% and 95%).
In other words, abundant interactions within the NAC region
and between the NAC and C-terminal regions are present in
the basin IA structures of the wild-type αS. We also note
interactions between the NAC region and part of the N-
terminal region with the C-terminal region (up to 45%)
between Val55-Gly86 and Glu104-Tyr136. Less abundant (5%)
intramolecular interactions between the N-terminal (Leu8-
Val16) and C-terminal (Gly132-Ala140) regions are also
observed in the wild-type αS basin IA structures. Similar to
the basin IA structures, abundant intramolecular interactions
between the part of the NAC region and part of the C-terminal
region are also detected between residues Thr72-Ile88 and
Ile88-Val118 and between Ala90-Asn103 with Glu104-Pro120.
However, the interactions between the NAC- and C-terminal
regions with the N-terminal region (Met1-Ala18) completely
disappear in the basin IB structures of the wild-type αS. Instead,
we observe an increase in the abundance of intramolecular
interactions within the N-terminal region between Met1-Lys10
and Gly14-Gly25 by up to 40%.
The A30P mutant-type αS structures also present significant
variances in the intramolecular interactions present in the
structures located in the two most favorable PMF basins
(Figure 7, bottom). For example, the abundance of intra-
molecular interactions between Gly106-Ala124 with Val82-
Lys102 increase in abundance by up to 20% in the basin IB
structures in comparison to the basin IA structures of the A30P
mutant-type αS. However, the opposite trend is observed for
the intramolecular interactions between Thr72-Gly106 and
Ala56-Thr72. Furthermore, we note a decrease in the
intramolecular interactions between Val66-Val82 and Pro108-
Pro128 as well as between Gln62-Ala90 and Ala29-Val52 in the
basin IB structures in comparison to the basin IA structures of
the A30P mutant-type αS. The less abundant interactions
between residues Met1-Glu20 and the NAC region completely
disappear in the basin IB structures in comparison to the basin
IA structures of the A30P mutant-type αS.
The structural and thermodynamic properties of the A30P
mutant-type and wild-type αS proteins reported herein indicate
an increased rate of aggregation upon A30P mutation. The
decrease in helicity around the A30P mutation site as well as
the increase in β-sheet formation in the NAC and C-terminal
regions are proposed to accelerate the oligomerization, which is
an initial step in the fibrillization mechanism of αS.29
Furthermore, the decreased long-range as well as NAC and
C-terminal region intramolecular interactions upon A30P
mutation are associated with an increased rate of aggregation
for the A30P mutant-type rather than wild-type αS protein. The
reported trends in the Rg and Gibbs free energy values of the
wild-type and A30P mutant-type αS proteins further agree with
a destabilized structure of the A30P mutant-type αS in
comparison to the wild-type, which further is linked to the
increased rate of aggregation upon A30P mutation. However,
the lack of β-sheet formation in the N-terminal region of the
A30P mutant-type αS protein indicates that oligomerization
and/or aggregation via the N-terminal region is hindered.29 We
find that β-sheet structure formation in the NAC- and C-
terminal regions is more preferred upon A30P mutation of the
wild-type αS protein. These findings indicate that the
oligomerization and/or aggregation tendency is larger for the
A30P mutant-type αS protein due to the increased formation of
β-sheet structure in these regions, which is directly linked to the
reactivity in the oligomerization process. Based on these
quantitative findings, our results agree with those experimental
studies that reported an increased oligomerization rate for the
A30P mutant-type αS in comparison to the wild-type
αS.11,12,14,15,20−23 The increased rate of oligomerization based
on the structural properties at the monomeric level, suggest
that the A30P mutant-type αS protein is more likely to be
neurotoxic than the wild-type αS, which is in agreement with
few experimental studies.23 Our findings based on PMF
surfaces of the wild-type and A30P mutant-type α-synculein
indicate that both αS proteins exhibit two favorable PMF basins
with different secondary and tertiary structural characteristics.
However, transitions between the structures located in these
two favorable PMF basins require the overriding of large energy
barriers for the wild-type αS but not the A30P mutant-type αS
protein. Overall, this study shows that the A30P mutation
significantly impacts the structural and thermodynamic proper-
ties of the wild-type αS protein not only at the mutation site
but also throughout the protein structure. Newly developed
small molecules or antibodies that target the specific β-sheet
forming residues in the NAC and C-terminal regions that we
report in this study may hinder the formation of toxic A30P
mutant-type αS oligomers. Furthermore, the information
gained using our secondary structure transition stability method
also provides knowledge about the most preferred secondary
structure conversion resulting in the formation of the β-sheet
structure for the residues located in the NAC- and C-terminal
regions. From these findings, small molecules can be designed
that specifically target the residues directly before the formation
of a β-sheet structure at the monomeric level.
■ METHODS
Parallel tempering or replica exchange molecular dynamics (REMD)
simulations utilize several replicas at different temperatures that
exchange throughout the course of the simulation in order to allow the
sampling of different minimum energy conformations within the same
simulation, unlike classical MD.47 As a result, REMD simulations
provide enhanced conformational sampling of protein structures,
which is a necessity for simulations of intrinsically disordered
proteins.47,48 Therefore, we performed REMD simulations on the
full length wild-type and A30P mutant-type αS proteins using the
Onufriev−Bashford−Case generalized Born implicit solvent
model.47,49 An implicit solvent model was used in order to prevent
errors due to confined aqueous volume or nonconstant heat capacity
in explicit water REMD simulations.37,38 The REMD simulations were
performed with the AMBER 11 software package along with Amber
ff99SB potential functions for the protein.50,51 A total number of 56
replicas were utilized with temperatures exponentially distributed
between 283 and 490 K.52 The initial structures were equilibrated for
500 ns for each replica with a time step of 2 fs. Each replica was then
simulated for a total of 40 ns with exchanges attempted every 5 ps
while trajectories were saved every 500 steps. Langevin dynamics with
a collision frequency of 2 ps−1 was used to control the temper-
ature.53,54 The particle mesh Ewald method with a cutoff value of 450
Å was used to treat the long-range interactions, and bonds were
constrained using the SHAKE algorithm.53,54 Based on the cumulative
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secondary structure abundance,37,38 we concluded that both the wild-
type and A30P mutant-type αS simulations reached convergence after
20 ns of simulation per replica (see the Supporting Information). The
structural and thermodynamic properties of the structures obtained
after convergence were calculated for the replica closest to
physiological temperature (310 K). The DSSP program, which
incorporates hydrogen bond criteria, was used to analyze the
secondary structure components of the wild- and A30P mutant-type
αS.55 In addition, the stability of residual secondary structure
transitions of the wild-type and A30P mutant-type αS was assessed
using our recently published theoretical strategy.39,40 Intramolecular
interactions were considered to occur if at least one heavy atom (C, O,
N, S) of a specific residue was at least ≤20 Å from the heavy atom of
another residue. A cutoff distance of 20 Å was utilized in order to
account for any long-range intramolecular interactions observed
experimental from residual dipolar coupling measurements. Thermo-
dynamic analysis was performed on the 20 000 structures obtained
after convergence for both the wild-type and A30P mutant-type αS
using the molecular mechanics/Poisson−Boltzmann surface area
(MM/PBSA) method and potential mean force (PMF) calcula-
tions.37,38,56,57 The PMF calculations were based on coordinates of
end-to-end distance (RE‑E), which is the distance between the N-
terminus backbone N atom and the C-terminus backbone carboxyl O
atom, and radius of gyration (Rg) as in our previous studies with
intrinsically disordered fibrillogenic peptides.37,38 The thermodynamic
calculations utilizing the MM/PBSA method used dielectric constant
values of 1 and 80 for the protein and solvent environment,
respectively. Furthermore, the entropy values were estimated using
the normal-mode analysis (NMA).58 Quasi-harmonic entropy
calculations using the Schlitter method were attempted,59 however,




Convergence figures for the wild-type and A30P mutant-type
αS. Cconvergence figures for the secondary structure transition
stabilities and the PMF surfaces of both peptides. Description
of tertiary structural properties of both peptides for the least
favorable basins on the PMF surfaces. This material is available
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